Tech companies looking to overhaul the health insurance industry have made much-hyped entries onto the public market. But they have yet to prove they can make money in the long run.
The stocks of two of the sector’s star companies — Oscar Health and Clover Health — have plummeted since their initial trades. They’re still racking up losses and the proportion of premiums they spend on medical claims outpaces that of lower-tech health insurance competitors, analysts tell STAT.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
